CTSA Pharmaceutical Assets Portal: Matching Academia and Industry for Drug Repositioning

Friday, December 4, 2009
9:00 a.m. – noon
Lipsett Amphitheater, Building 10, NIH Campus, Bethesda, MD

View Agenda
Register Now

Drug repositioning, or finding new uses for drugs originally designed for another purpose, has become more important recently as many pharmaceutical companies are seeing their drug pipelines dry up. With the high cost of drug research and development, drug repositioning offers a way to explore these previously shelved assets. The Clinical and Translational Science Award (CTSA) Pharmaceutical Assets Portal is a tool that aims to match researchers’ scientific knowledge of targets and diseases with the repositioning needs of the pharmaceutical industry to potentially increase the number of approved drugs for alternative uses.

Join your colleagues for a half-day conference that will bring together leaders in the pharmaceutical industry, government, and research to explore current drug repositioning efforts.

For more information and to register, visit http://palladianpartners.com/Pharm-Assets. Registration is requested by November 25, 2009. This event will be videocast at http://videocast.nih.gov.